Services DMPK Toxicity In Rodents, Dogs and Monkeys
Toxicity In Rodents, Dogs and Monkeys
BioDuro supports exploratory toxicology studies in rodents, dogs, and non-human primates to help discovery teams evaluate safety signals, understand compound liabilities, and make more informed candidate selection decisions during preclinical development.
Early Toxicology Support for Discovery Programs
Our toxicology and DMPK teams enable early safety assessment strategies designed to identify potential risks, characterize tolerability, and generate translational insights across small molecule and complex modality programs.
Exploratory Toxicology Studies
Discovery-stage toxicity studies supporting early safety evaluation, dose range finding, and compound selection across multiple species.
- Rodent and non-rodent studies
- Dose escalation support
- Early tolerability assessment
Integrated DMPK & Toxicology Insight
Combined toxicology and pharmacokinetic evaluation helping teams better understand exposure, metabolism, and safety relationships during discovery.
- PK/TK evaluation
- Exposure-response assessment
- Compound liability identification
Translational Safety Evaluation
Capabilities supporting interpretation of toxicology findings and progression decisions for preclinical programs.
- Histopathology support
- Clinical pathology analysis
- Discovery-stage safety guidance
Toxicology & Safety Assessment Capabilities
BioDuro supports exploratory toxicology studies through in vivo pharmacology, toxicokinetic evaluation, clinical pathology, and integrated discovery safety workflows.
Rodent Toxicology Studies
Discovery-stage toxicity assessment supporting dose range finding and tolerability evaluation.
Dog & Non-Human Primate Studies
Non-rodent exploratory toxicology support for translational safety assessment.
Toxicokinetic (TK) Analysis
Exposure evaluation supporting interpretation of toxicology findings and safety margins.
Clinical Pathology & Histology
Pathology support helping teams evaluate compound-related biological effects during preclinical studies.
BioDuro supports exploratory toxicology studies in rodents, dogs, and non-human primates to help evaluate tolerability, safety signals, and compound liabilities during discovery and preclinical development.
Exploratory toxicology studies help discovery teams identify early safety risks, better understand dose tolerability, and support candidate selection decisions before formal GLP toxicology studies.
Yes. BioDuro combines toxicology and DMPK evaluation to help teams better understand exposure-response relationships, toxicokinetics, and compound-related safety findings.
Studies may include clinical observations, body weight monitoring, clinical pathology, toxicokinetic analysis, and histopathology evaluation depending on program goals.
Yes. BioDuro uses exploratory safety assessment strategies for small molecules, peptides, ADCs, and other complex therapeutic programs during discovery and preclinical development.
Download the DMPK Services Overview
Explore BioDuro’s DMPK and exploratory toxicology capabilities supporting ADME, pharmacokinetics, bioanalysis, and preclinical safety assessment across discovery programs.
Related Resources
Browse resources showcasing BioDuro’s capabilities in exploratory toxicology, toxicokinetics, and drug safety assessment across discovery and preclinical development programs.
Related DMPK Services
Discovery-stage toxicology studies designed to identify potential safety risks, assess tolerability, and support informed compound progression decisions.